HC Wainwright Analysts Reduce Earnings Estimates for ABEO
Abeona Therapeutics Inc (NASDAQ:ABEO – Free Report) – Analysts at HC Wainwright cut their Q1 2025 EPS estimates for Abeona Therapeutics in a note issued to investors on Monday, March 24th. HC Wainwright analyst R. Selvaraju now anticipates that the biopharmaceutical company will earn ($0.36) per share for the quarter, down from their prior estimate […]
More Stories
Capita (OTCMKTS:CTAGY) & Flywire (NASDAQ:FLYW) Critical Survey
Capita (OTCMKTS:CTAGY – Get Free Report) and Flywire (NASDAQ:FLYW – Get Free Report) are both business services companies, but which...
Ealixir (EAXR) versus Its Peers Head-To-Head Contrast
Profitability This table compares Ealixir and its competitors’ net margins, return on equity and return on assets. Net Margins Return...
StockNews.com Begins Coverage on Infinera (NASDAQ:INFN)
Equities researchers at StockNews.com began coverage on shares of Infinera (NASDAQ:INFN – Get Free Report) in a research note issued...
StockNews.com Begins Coverage on Cross Country Healthcare (NASDAQ:CCRN)
Analysts at StockNews.com assumed coverage on shares of Cross Country Healthcare (NASDAQ:CCRN – Get Free Report) in a note issued...
Reviewing Volkswagen (OTC:VWAGY) & Ideanomics (NASDAQ:IDEX)
Profitability This table compares Volkswagen and Ideanomics’ net margins, return on equity and return on assets. Net Margins Return on...
Galmed Pharmaceuticals (NASDAQ:GLMD) Coverage Initiated at StockNews.com
StockNews.com assumed coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Free Report) in a report released on Thursday. The...